Double-chimera proteins to enhance recruitment of endothelial cells and their progenitor cells.
BACKGROUND
Enhanced attraction of selective vascular reparative cells is of great importance in order to increase vascular patency after endovascular treatments. We aimed to evaluate efficient attachment of endothelial cells and their progenitors on surfaces coated with mixture of specific antibodies, L-selectin and VE-cadherin, with prohibited platelet attachment.


METHODS
The most efficient conditions for coating of L-selectin-Fc chimera and VE-cadherin-Fc chimera proteins were first determined by protein coating on ELISA plates. The whole processes were repeated on titanium substrates, which are commonly used to coat stents. Endothelial progenitor cells (EPCs) and human umbilical vein endothelial cells (HUVECs) were isolated and characterized by flow cytometry. Cell attachment, growth, proliferation, viability and surface cytotoxicity were evaluated using nuclear staining and MTT assay. Platelet and cell attachment were evaluated using scanning electron microscopy.


RESULTS
Optimal concentration of each protein for surface coating was 50 ng/ml. The efficacy of protein coating was both heat and pH independent. Calcium ions had significant impact on simultaneous dual-protein coating (P<0.05). Coating stability data revealed more than one year stability for these coated proteins at 4°C. L-selectin and VE-cadherin (ratio of 50:50) coated surface showed highest EPC and HUVEC attachment, viability and proliferation compared to single protein coated and non-coated titanium surfaces (P<0.05). This double coated surface did not show any cytotoxic effect.


CONCLUSIONS
Surfaces coated with L-selectin and VE-cadherin are friendly surface for EPC and endothelial cell attachment with less platelet attachment. These desirable factors make the L-selectin and VE-cadherin coated surfaces perfect candidate endovascular device.
Dept of Cardiology, Isfahan University of Medical Sciences, Isfahan, Iran. behjati@med.mui.ac.ir
M
M
Behjati
M
M
Kazemi
M
M
Hashemi
S H
SH
Zarkesh-Esfahanai
E
E
Bahrami
B
B
Hashemi-Beni
R
R
Ahmadi
D000818:Animals; D015703:Antigens, CD / Q000008:administration & dosage* / Q000235:genetics; D015820:Cadherins / Q000008:administration & dosage* / Q000235:genetics; D018929:Cell Culture Techniques / Q000379:methods*; D045744:Cell Line, Tumor; D002478:Cells, Cultured; D002678:Chimera; D020099:Coated Materials, Biocompatible / Q000008:administration & dosage; D042783:Endothelial Cells / Q000502:physiology* / Q000648:ultrastructure; D061307:Human Umbilical Vein Endothelial Cells / Q000502:physiology / Q000648:ultrastructure; D006801:Humans; D019041:L-Selectin / Q000008:administration & dosage* / Q000235:genetics; D051379:Mice; D013234:Stem Cells / Q000502:physiology* / Q000648:ultrastructure; D000099152:Cadherin 5
D015703:Antigens, CD; D015820:Cadherins; D020099:Coated Materials, Biocompatible; D019041:L-Selectin; D000099152:Cadherin 5